What’s new in Birt–Hogg–Dubé syndrome?

References

• Houweling AC, Gijezen LM, Jonker MA et al. Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome: an analysis of 115 FLCN mutation carriers from 35 BHD families. Br. J. Cancer 105(12), 1912–1919 (2011).
   PubMed Web of Science ®Google Scholar
• Menko FH, van Steensel MA, Giraud S et al.; European BHD Consortium. Birt–Hogg–Dubé syndrome: diagnosis and management. Lancet Oncol. 10(12), 1199–1206 (2009).
   PubMed Web of Science ®Google Scholar
• Kluger N, Giraud S, Coupier I et al. Birt–Hogg–Dubé syndrome: clinical and genetic studies of 10 French families. Br. J. Dermatol. 162(3), 527–537 (2010).
   PubMed Web of Science ®Google Scholar
• Schmidt LS, Nickerson ML, Warren MB et al. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt–Hogg–Dubé syndrome. Am. J. Hum. Genet. 76(6), 1023–1033 (2005).
   PubMed Web of Science ®Google Scholar
• Orlova KA, Crino PB. The tuberous sclerosis complex. Ann. NY Acad. Sci. 1184, 87–105 (2010).
   PubMed Web of Science ®Google Scholar
• Bissler JJ, McCormack FX, Young LRet al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358(2), 140–151 (2008).
   PubMed Web of Science ®Google Scholar
• Okimoto K, Sakurai J, Kobayashi T et al. A germ-line insertion in the Birt–Hogg–Dubé (BHD) gene gives rise to the Nihon rat model of inherited renal cancer. Proc. Natl Acad. Sci. USA 101(7), 2023–2027 (2004).
   PubMedGoogle Scholar
• Hasumi Y, Baba M, Ajima R et al. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc. Natl Acad. Sci. USA 106(44), 18722–18727 (2009).
   PubMed Web of Science ®Google Scholar
• Baba M, Furihata M, Hong SB et al. Kidney-targeted Birt–Hogg–Dubé gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J. Natl Cancer Inst. 100(2), 140–154 (2008).
   PubMedGoogle Scholar
• Chen J, Futami K, Petillo D et al. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS ONE 3(10), e3581 (2008).
   Web of Science ®Google Scholar
• Baba M, Hong SB, Sharma N et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc. Natl Acad. Sci. USA 103(42), 15552–15557 (2006).
   PubMed Web of Science ®Google Scholar
• Hudon V, Sabourin S, Dydensborg AB et al. Renal tumour suppressor function of the Birt–Hogg–Dubé syndrome gene product folliculin. J. Med. Genet. 47(3), 182–189 (2010).
   PubMed Web of Science ®Google Scholar
• Hartman TR, Nicolas E, Klein-Szanto A et al. The role of the Birt–Hogg–Dubé protein in mTOR activation and renal tumorigenesis. Oncogene 28(13), 1594–1604 (2009).
   PubMed Web of Science ®Google Scholar
• van Slegtenhorst M, Khabibullin D, Hartman TR, Nicolas E, Kruger WD, Henske EP. The Birt–Hogg–Dubé and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. J. Biol. Chem. 282(34), 24583–24590 (2007).
   PubMedGoogle Scholar
• Claessens T, Weppler SA, van Geel M et al. Neuroendocrine carcinoma in a patient with Birt–Hogg–Dubé syndrome. Nat. Rev. Urol. 7(10), 583–587 (2010).
   PubMedGoogle Scholar
• Preston RS, Philp A, Claessens T et al. Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 30(10), 1159–1173 (2011).
   PubMedGoogle Scholar
• Klomp JA, Petillo D, Niemi NM et al. Birt–Hogg–Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med. Genomics 3, 59 (2010).
   PubMed Web of Science ®Google Scholar
• Krishnan B, Truong LD. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum. Pathol. 33(1), 68–79 (2002).
   PubMed Web of Science ®Google Scholar
• Hong SB, Oh H, Valera VA et al. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling. Mol. Cancer 23(9), 160 (2010).
   Google Scholar
• Yang Y, Padilla-Nash HM, Vira MA et al. The UOK 257 cell line: a novel model for studies of the human Birt–Hogg–Dubé gene pathway. Cancer Genet. Cytogenet. 180(2), 100–109 (2008).
   PubMedGoogle Scholar
• Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC. Loss of the Birt–Hogg–Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription. Oncogene 30(22), 2534–2546 (2011).
   PubMed Web of Science ®Google Scholar
• Grinberg AV, Kerppola T. Both Max and TFE3 cooperate with Smad proteins to bind the plasminogen activator inhibitor-1 promoter, but they have opposite effects on transcriptional activity. J. Biol. Chem. 278(13), 11227–11236 (2003).
   PubMed Web of Science ®Google Scholar
• Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS ONE 5(12), e15793 (2010).
   PubMed Web of Science ®Google Scholar
• Singh SR, Zhen W, Zheng Z et al. The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance. Oncogene 25(44), 5933–5941 (2006).
   PubMed Web of Science ®Google Scholar
• Cardenas-Rodriguez M, Badano JL. Ciliary biology: understanding the cellular and genetic basis of human ciliopathies. Am. J. Med. Genet. C. Semin. Med. Genet. 151C(4), 263–280 (2009).
   PubMed Web of Science ®Google Scholar
• Jones C, Chen P. Primary cilia in planar cell polarity regulation of the inner ear. Curr. Top. Dev. Biol. 85, 197–224 (2008).
   PubMedGoogle Scholar
• McNeill H. Planar cell polarity and the kidney. J. Am. Soc. Nephrol. 20(10), 2104–2111 (2009).
   PubMedGoogle Scholar
• Waters AM, Beales PL. Ciliopathies: an expanding disease spectrum. Pediatr. Nephrol. 26(7), 1039–1056 (2011).
   PubMed Web of Science ®Google Scholar
• Gong Y, Mo C, Fraser SE. Planar cell polarity signalling controls cell division orientation during zebrafish gastrulation. Nature 430(7000), 689–693 (2004).
   PubMed Web of Science ®Google Scholar
• Nookala RK, Langemeyer L, Pacitto A et al. Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer. Open Biol. 2(8), 120071 (2012).
   PubMed Web of Science ®Google Scholar
• Das A, Guo W. Rabs and the exocyst in ciliogenesis, tubulogenesis and beyond. Trends Cell Biol. 21(7), 383–386 (2011).
   PubMed Web of Science ®Google Scholar
• Chesneau L, Dambournet D, Machicoane M et al. An ARF6/Rab35 GTPase cascade for endocytic recycling and successful cytokinesis. Curr. Biol. 22(2), 147–153 (2012).
   PubMed Web of Science ®Google Scholar
• Omori Y, Zhao C, Saras A et al. Elipsa is an early determinant of ciliogenesis that links the IFT particle to membrane-associated small GTPase Rab8. Nat. Cell Biol. 10(4), 437–444 (2008).
   PubMed Web of Science ®Google Scholar
• Korolchuk VI, Saiki S, Lichtenberg M et al. Lysosomal positioning coordinates cellular nutrient responses. Nat. Cell Biol. 13(4), 453–460 (2011).
   PubMed Web of Science ®Google Scholar
• van Steensel MA, Verstraeten VL, Frank J et al. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt–Hogg–Dubé patients. J. Invest. Dermatol. 127(3), 588–593 (2007).
   PubMedGoogle Scholar
• Misago N, Kimura T, Narisawa Y. Fibrofolliculoma/trichodiscoma and fibrous papule (perifollicular fibroma/angiofibroma): a revaluation of the histopathological and immunohistochemical features. J. Cutan. Pathol. 36(9), 943–951 (2009).
   PubMed Web of Science ®Google Scholar
• Mentzel T, Kutzner H, Requena L, Hartmann A. [Skin tumors as marker lesions for tumor syndromes]. Pathologe 31(6), 489–496 (2010).
   PubMedGoogle Scholar
• Hofbauer GF, Marcollo-Pini A, Corsenca A et al. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br. J. Dermatol. 159(2), 473–475 (2008).
   PubMed Web of Science ®Google Scholar
• Horsley V, O’Carroll D, Tooze R et al. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell 126(3), 597–609 (2006).
   PubMed Web of Science ®Google Scholar
• Li S, Thangapazham RL, Wang JA et al. Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis. Nat. Commun. 2, 235 (2011).
   PubMedGoogle Scholar
• Farrant PB, Emerson R. Letter: hyfrecation and curettage as a treatment for fibrofolliculomas in Birt–Hogg–Dubé syndrome. Dermatol. Surg. 33(10), 1287–1288 (2007).
   PubMedGoogle Scholar
• Rohatgi R, Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. Science 317(5836), 372–376 (2007).
   PubMed Web of Science ®Google Scholar
• Simons M, Gloy J, Ganner A et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 37(5), 537–543 (2005).
   PubMed Web of Science ®Google Scholar
• Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr. Drug Targets 9(7), 565–570 (2008).
   PubMed Web of Science ®Google Scholar
• Lauth M, Toftgård R. The Hedgehog pathway as a drug target in cancer therapy. Curr. Opin. Investig. Drugs 8(6), 457–461 (2007).
   PubMedGoogle Scholar
• Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat. Rev. Urol. 7(5), 277–285 (2010).
   PubMed Web of Science ®Google Scholar
• Lingaas F, Comstock KE, Kirkness EF et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum. Mol. Genet. 12(23), 3043–3053 (2003).
   PubMed Web of Science ®Google Scholar